280 related articles for article (PubMed ID: 27469493)
1. Telangiectatic osteosarcoma: a review of 87 cases.
Angelini A; Mavrogenis AF; Trovarelli G; Ferrari S; Picci P; Ruggieri P
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2197-207. PubMed ID: 27469493
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
Zhang Q; Niu XH; Cai YB; Hao L; Ding Y
Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1114-7. PubMed ID: 18005614
[TBL] [Abstract][Full Text] [Related]
3. [Osteosarcoma lung metastases. Survival after chemotherapy and surgery].
Farfalli GL; Albergo JI; Lobos PA; Smith DE; Streitenberger PD; Pallotta Rodríguez MG; Aponte-Tinao LA
Medicina (B Aires); 2015; 75(2):87-90. PubMed ID: 25919869
[TBL] [Abstract][Full Text] [Related]
4. Telangiectatic osteosarcoma.
Colomina J; Peiro A; Trullols L; Garcia I
J Orthop Surg (Hong Kong); 2013 Apr; 21(1):96-9. PubMed ID: 23629998
[TBL] [Abstract][Full Text] [Related]
5. [Telangiectatic osteosarcoma: report of 10 cases].
Zhang Q; Cai Y; Niu X; Hao L; Ding Y; Yu F
Zhonghua Wai Ke Za Zhi; 2000 Dec; 38(12):903-5, 50. PubMed ID: 11832192
[TBL] [Abstract][Full Text] [Related]
6. A Novel System for the Surgical Staging of Primary High-grade Osteosarcoma: The Birmingham Classification.
Jeys LM; Thorne CJ; Parry M; Gaston CL; Sumathi VP; Grimer JR
Clin Orthop Relat Res; 2017 Mar; 475(3):842-850. PubMed ID: 27138473
[TBL] [Abstract][Full Text] [Related]
7. Nonmetastatic osteosarcoma of the extremity with pathologic fracture at presentation: local and systemic control by amputation or limb salvage after preoperative chemotherapy.
Bacci G; Ferrari S; Longhi A; Donati D; Manfrini M; Giacomini S; Briccoli A; Forni C; Galletti S
Acta Orthop Scand; 2003 Aug; 74(4):449-54. PubMed ID: 14521297
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P
Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923
[TBL] [Abstract][Full Text] [Related]
9. Pathologic fracture in osteosarcoma : prognostic importance and treatment implications.
Scully SP; Ghert MA; Zurakowski D; Thompson RC; Gebhardt MC
J Bone Joint Surg Am; 2002 Jan; 84(1):49-57. PubMed ID: 11792779
[TBL] [Abstract][Full Text] [Related]
10. Pathologic fracture does not influence local recurrence and survival in high-grade extremity osteosarcoma with adequate surgical margins.
Xie L; Guo W; Li Y; Ji T; Sun X
J Surg Oncol; 2012 Dec; 106(7):820-5. PubMed ID: 22740310
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant Chemotherapy Followed by Delayed Surgery: Is it Necessary for All Patients With Nonmetastatic High-Grade Pelvic Osteosarcoma?
Xu J; Xie L; Guo W
Clin Orthop Relat Res; 2018 Nov; 476(11):2177-2186. PubMed ID: 29912746
[TBL] [Abstract][Full Text] [Related]
12. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience.
Mialou V; Philip T; Kalifa C; Perol D; Gentet JC; Marec-Berard P; Pacquement H; Chastagner P; Defaschelles AS; Hartmann O
Cancer; 2005 Sep; 104(5):1100-9. PubMed ID: 16015627
[TBL] [Abstract][Full Text] [Related]
13. Is Microscopic Vascular Invasion in Tumor Specimens Associated with Worse Prognosis in Patients with High-grade Localized Osteosarcoma?
Tsuda Y; Tsoi K; Stevenson JD; Parry MC; Fujiwara T; Sumathi V; Jeys LM
Clin Orthop Relat Res; 2020 Jun; 478(6):1190-1198. PubMed ID: 31904683
[TBL] [Abstract][Full Text] [Related]
14. [Survival analysis and the effects of prognostic factors in patients treated for osteosarcoma].
Ozger H; Eralp L; Atalar AC; Toker B; Ayan I; Kebudi R; Bağbek S; Başaran M; Ağaoğlu F; Dizdar Y; Bilgiç B
Acta Orthop Traumatol Turc; 2007; 41(3):211-9. PubMed ID: 17876121
[TBL] [Abstract][Full Text] [Related]
15. What are the factors that affect survival and relapse after local recurrence of osteosarcoma?
Takeuchi A; Lewis VO; Satcher RL; Moon BS; Lin PP
Clin Orthop Relat Res; 2014 Oct; 472(10):3188-95. PubMed ID: 24980644
[TBL] [Abstract][Full Text] [Related]
16. Pathological fractures in predicting clinical outcomes for patients with osteosarcoma.
Chung LH; Wu PK; Chen CF; Weng HK; Chen TH; Chen WM
BMC Musculoskelet Disord; 2016 Dec; 17(1):503. PubMed ID: 28031047
[TBL] [Abstract][Full Text] [Related]
17. Telangiectatic osteosarcoma of the extremity: neoadjuvant chemotherapy in 24 cases.
Bacci G; Ferrari S; Ruggieri P; Biagini R; Fabbri N; Campanacci L; Bacchini P; Longhi A; Forni C; Bertoni F
Acta Orthop Scand; 2001 Apr; 72(2):167-72. PubMed ID: 11372948
[TBL] [Abstract][Full Text] [Related]
18. Pathologic fracture does not influence prognosis in stage IIB osteosarcoma: a case-control study.
Zuo D; Zheng L; Sun W; Hua Y; Cai Z
World J Surg Oncol; 2013 Jun; 11():148. PubMed ID: 23799947
[TBL] [Abstract][Full Text] [Related]
19. Survival and prognostic factors in Chinese patients with osteosarcoma: 13-year experience in 365 patients treated at a single institution.
Wang W; Yang J; Wang Y; Wang D; Han G; Jia J; Xu M; Bi W
Pathol Res Pract; 2017 Feb; 213(2):119-125. PubMed ID: 28040328
[TBL] [Abstract][Full Text] [Related]
20. Effect of increases in tumor volume after neoadjuvant chemotherapy on the outcome of stage II osteosarcoma regardless of histological response.
Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jung ST; Jeon DG
J Orthop Sci; 2009 May; 14(3):292-7. PubMed ID: 19499296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]